Potassium Chloride Extended-Release Tablets Recall: Failed Dissolution Specifications
Major Pharmaceuticals recalls Potassium Chloride Extended-Release Tablets due to failed dissolution specifications. This could affect medication effectiveness. Check your product details and contact the manufacturer for instructions.
Recall notice
Failed Dissolution Specifications.
Contact the company
What happened, in plain English
Major Pharmaceuticals is recalling Potassium Chloride Extended-Release Tablets because they failed dissolution specifications. This means the tablets may not release potassium chloride properly, potentially affecting medication effectiveness. Consumers should check their product details and contact the manufacturer for instructions. Read more at govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications · Updated August 17, 2026 · FDA enforcement record: FDA #D-0221-2025
Cite this page
“Potassium Chloride Extended-Release Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0221-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0221-2025%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release potassium chloride as intended. This could lead to improper medication effectiveness. The exact risk level is not clearly described in the recall notice.
Who’s affected
People who have the Potassium Chloride Extended-Release Tablets (10 mEq/750 mg) with NDC 0904-7216-61 and lot number T05224 are affected. Those using these tablets for medical purposes are most at risk.
How to tell if you have this one
Check for the product name 'Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters)'. Look for NDC 0904-7216-61 and lot number T05224 on the packaging.
- Brand
Major Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 0904-7216-61 and lot number T05224 on the packaging to confirm if your product is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 13 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0221-2025 (January 30, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0221-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.